The interaction of oncogene and tumour suppressor gene defects with cytotoxic drugs: its role in the improvement of selective toxicity and the development of new drugs in clinical oncology

R D Petty, Russell David Petty

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)186-9
Number of pages4
JournalClinical Oncology
Volume8
Issue number3
Publication statusPublished - 1996

Keywords

  • Antineoplastic Agents
  • Drug Design
  • Drug Resistance, Neoplasm
  • Genes, Tumor Suppressor
  • Genes, myc
  • Genes, p53
  • Genetic Therapy
  • Humans
  • Neoplasms
  • Oncogenes

Cite this

@article{bb10e3009a9e47dcbee8e9b53b0ca955,
title = "The interaction of oncogene and tumour suppressor gene defects with cytotoxic drugs: its role in the improvement of selective toxicity and the development of new drugs in clinical oncology",
keywords = "Antineoplastic Agents, Drug Design, Drug Resistance, Neoplasm, Genes, Tumor Suppressor, Genes, myc, Genes, p53, Genetic Therapy, Humans, Neoplasms, Oncogenes",
author = "Petty, {R D} and Petty, {Russell David}",
year = "1996",
language = "English",
volume = "8",
pages = "186--9",
journal = "Clinical Oncology",
issn = "0936-6555",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - The interaction of oncogene and tumour suppressor gene defects with cytotoxic drugs

T2 - its role in the improvement of selective toxicity and the development of new drugs in clinical oncology

AU - Petty, R D

AU - Petty, Russell David

PY - 1996

Y1 - 1996

KW - Antineoplastic Agents

KW - Drug Design

KW - Drug Resistance, Neoplasm

KW - Genes, Tumor Suppressor

KW - Genes, myc

KW - Genes, p53

KW - Genetic Therapy

KW - Humans

KW - Neoplasms

KW - Oncogenes

M3 - Article

VL - 8

SP - 186

EP - 189

JO - Clinical Oncology

JF - Clinical Oncology

SN - 0936-6555

IS - 3

ER -